Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inphilco is a Philippines-based animal health and veterinary products company focused on commercial distribution rather than novel drug R&D. Publicly available sources describe the business as a Manila/Quezon City-based distributor and wholesaler serving poultry, swine, aquaculture, pets, and feed mills, with offerings spanning animal nutrition, animal health, veterinary medicines, biologicals, and feed raw materials. The company appears to operate as a commercial partner for third-party products, including a documented distribution agreement with Avivagen for OxC-beta Livestock in the Philippines. Available evidence does not indicate an internal human biotech pipeline, clinical-stage therapeutics portfolio, or proprietary drug discovery platform. For biotech diligence purposes, Inphilco is best characterized as an active private veterinary/animal-health commercial distributor in the Philippines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inphilco.